FDA Recalls Fentanyl Injectable Syringes Due to Sterility Concerns
Central Admixture Pharmacy Services is recalling fentanyl 2500 mcg/50 mL injections nationwide due to lack of assured sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for an injectable opioid lacking assured sterility. While no reported illnesses are mentioned in the source, sterility failure in injectable medications constitutes a high-risk-of-harm product that could cause serious infection.
Plain-English summary
Central Admixture Pharmacy Services Inc is recalling fentanyl 2500 mcg/50 mL (50 mcg/mL) syringes distributed nationwide. The recall is due to a lack of assurance of sterility of the product.
Affected product includes 476 syringes with lot numbers 17-275464 (expiration 10/4/2023) and 17-275850 (expiration 10/11/2023). The product NDC is 71286-2003-3.
Fentanyl is a potent opioid medication administered by injection. Failure to ensure sterility in injectable medications poses a serious risk of infection to patients. Consumers and healthcare providers who have received or dispensed this product should contact the recalling firm or their healthcare provider for further guidance.
The manufacturer is located at 7935 Dunbrook Road, Suite C, San Diego, CA 92126.
The recalled product
- Product
- fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Injectable / Opioid
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot:17-275464
- Exp. 10/4/2023
- 17-275850
- Exp. 10/11/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 32 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22